Status: current, Defined. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4556285010 | Product containing botulinum toxin type B in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Initial character case insensitive | SNOMED CT core |
| 4556286011 | Botulinum toxin type B-containing product in parenteral dose form | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Botulinum toxin type B-containing product in parenteral dose form | Has active ingredient | Botulinum toxin type B | true | Inferred relationship | Some | 1 | |
| Botulinum toxin type B-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Some | ||
| Botulinum toxin type B-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some | ||
| Botulinum toxin type B-containing product in parenteral dose form | Is a | Botulinum toxin type B-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Botulinum toxin type B only product in parenteral dose form | Is a | True | Botulinum toxin type B-containing product in parenteral dose form | Inferred relationship | Some | |
| RimabotulinumtoxinB-containing product in parenteral dose form | Is a | False | Botulinum toxin type B-containing product in parenteral dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR